무증상성 단백뇨에 대한 단기 한약 투약 경과 : 증례보고
Progress of Short-Term Herbal Medicine Administration for Asymptomatic Proteinuria: Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This case reports a certain level of improvement for asymptomatic proteinuria with short-term administration of herbal medicine. Methods: In the first treatment phase, the patient was treated with Dangguisu-san (DGSS) for his rib fracture. In the second treatment phase, the patient was treated with a herbal formulation of Astragali and Angelicae Sinensis (A&As particle) for asymptomatic proteinuria. Results: Treatment with herbal medicine resulted in a decrease in the patient’s complaints regarding symptoms. Also, proteinuria-related items in hematology and urinalysis were improved. Conclusions: Herbal medicine therapy may be effective for proteinuria treatment.
Abstract
Objectives: This case reports a certain level of improvement for asymptomatic proteinuria with short-term administration of herbal medicine. Methods: In the first treatment phase, the patient was treated with Dangguisu-san (DGSS) for his rib fracture. In the second treatment phase, the patient was treated with a herbal formulation of Astragali and Angelicae Sinensis (A&As particle) for asymptomatic proteinuria. Results: Treatment with herbal medicine resulted in a decrease in the patient’s complaints regarding symptoms. Also, proteinuria-related items in hematology and urinalysis were improved. Conclusions: Herbal medicine therapy may be effective for proteinuria treatment.
참고문헌 (14)
- Clase CM, "Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk : a cohort study", Ann Intern Med, 154(5), pp.310~318 (2011)
- Mulè G, "Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria", Adv Exp Med Biol, 956, pp.279~306 (2017)
- Inker LA, "Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient: meta-analysis", Am J Kidney Dis, 64(1), pp.74~85 (2014)
- de Zeeuw D, "Unmet need in renal protection-do we need a more comprehensive approach?", Contrib Nephrol, 171, pp.157~160 (2011)
- Zhong Y, "Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases", Kidney Int, 84(6), pp.1108~1118 (2013)
- Zhang L, "Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial", Am J Kidney Dis, 64(1), pp.57~65 (2014)
- Cravedi P, "Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease", Br J Clin Pharmacol, 76(4), pp.516~523 (2013)
- Venkat KK, "Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment", South Med J, 97(10), pp.969~979 (2004)
- Simerville JA, "Urinalysis : a comprehensive review", Am Fam Physician, 71(6), pp.1153~1162 (2005)
- Yamagata K, "A long-term follow-up study of asymptomatic hematuria and", or proteinuria in adults, 1996, pp.45(5), 281~288
- Shen P, "Effect of Astragali and Angelica particle on proteinuria in Chinese patients with primary glomerulonephritis", J Tradit Chin Med, 36(3), pp.299~306 (2016)
- Li M, "Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy", J Ethnopharmacol, 133(2), pp.412~419 (2011)
- Huang LF, "The effect of Astragaloside IV on immune function of regulatory T cell mediated by high mobility group box 1 protein in vitro", Fitoterapia, 83(8), pp.1514~1522 (2012)
- Nalbantsoy A, "Evaluation of the immunomodulatory properties in mice and in vitro anti-inflammatory activity of cycloartane type saponins from Astragalus species", J Ethnopharmacol, 139(2), pp.574~581 (2012)